| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 305.4K | $2.55M | - | |
| CFO | 215.4K | $1.80M | - | |
| Dir | 119.9K | $1.00M | - | |
| VP | 104.1K | $870.3K | - | |
| Dir | 89.0K | $743.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 25, 2021 | Zoon Kathryn C62 | Director | Sell | 3,139 | $56.48 | $177,290.72 | -17.9% | +12.5% | -40.4% | |
| Mar 4, 2021 | Bailey Sue | Director | Sell | 8,168 | $92.37 | $754,478.16 | -25.1% | - | - | |
| Mar 1, 2021 | Havey Adam | EVP, Business Operations | Sale+OE | 37,279 | $99.30 | $3,701,646.98 | -32.8% | - | - | |
| Feb 8, 2021 | Kramer Robert | President And CEO | Sale+OE | 45,397 | $120.03 | $5,449,001.91 | -14.0% | - | - | |
| Jan 21, 2021 | Kramer Robert | President And CEO | Sale+OE | 24,132 | $110.03 | $2,655,177.00 | -8.0% | - | - | |
| Jan 15, 2021 | Kramer Robert | President And CEO | Sale+OE | 19,026 | $106.01 | $2,016,900.60 | -12.0% | - | - | |
| Nov 10, 2020 | El-Hibri Fuad | Chairman | Sale+OE | 39,391 | $91.79 | $3,615,680.11 | -1.7% | - | - | |
| Nov 3, 2020 | El-Hibri Fuad | Chairman | Sale+OE | 40,000 | $90.59 | $3,623,600.00 | -1.7% | - | - | |
| Sep 24, 2020 | El-Hibri Fuad | Chairman | Sell | 25,535 | $99.73 | $2,546,624.75 | -1.1% | - | - | |
| Sep 17, 2020 | El-Hibri Fuad | Chairman | Sell | 40,000 | $101.58 | $4,063,200.00 | -1.7% | - | - |